Ruah Alyamany: Evaluating Safety of TPO-RA Use in ITP After Splenectomy
Ruah Alyamany, Advanced Classical (Benign) Hematology Fellow at Mayo Clinic, shared a post on LinkedIn:
“Excited to share our latest study in ITP.
In clinical practice, esp. in classical (benign) hematology, safety and risk can be easily assumed rather than examined. In ITP, many patients receive TPO-RAs after splenectomy without full consideration of potential consequences. Here we take a closer look, evaluating their general safety in this setting and with a closer look at thrombosis.”
Read the full article here.
Title: Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP
Authors: Ruah Alyamany, Damon E Houghton, Meera Sridharan, Rajiv K Pruthi, Surbhi Shah, Richard C. Godby, Alexandra P Wolanskyj-Spinner, Ronald S. Go
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Nov 15, 2025, 12:24Thomas Reiser: Can AI Keep Up with Thrombosis Specialists?
-
Nov 15, 2025, 12:13Michael Makris on Immediate Suspension of Use of Plasma Derived FIX Concentrates in Punjab
-
Nov 15, 2025, 09:32Tushar Pandey: Hounoured to Be Part of Hematocon 2025
-
Nov 15, 2025, 09:11Lisa Murphy invites You to Join Her at Stroke Foundation’s Run4Stroke Marathon
-
Nov 15, 2025, 08:56Ahmed Bennis on Potential Use of P2Y12 Inhibitors as Safer Alternative in Monotherapy
-
Nov 15, 2025, 08:39Marika Nöjd: Donating Blood is An Easy Way to Do Good!
-
Nov 15, 2025, 08:19Joseph Caprini Released His UIP 2025 Session on VTE Recurrence Risk
-
Nov 15, 2025, 07:14Paul Bolaji Invites You to ”Thrombolytic Therapy in Acute Stroke in African Patients” Seminar
-
Nov 15, 2025, 07:03Carla Goulart Peron Explores The Role of Technology and Collaboration in Global Stroke Action